PTC Therapeutics Reports Second Quarter 2020 Financial Results and Provides a Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. CRWV

Go back to PTC Therapeutics Reports Second Quarter 2020 Financial Results and Provides a Corporate Update

PTC Therapeutics (PTCT) Misses Q2 EPS by 148c

August 5, 2020 5:47 PM EDT

PTC Therapeutics (NASDAQ: PTCT) reported Q2 EPS of ($2.78), $1.48 worse than the analyst estimate of ($1.30).

"We are pleased with the progress in our pipeline and the strong commercial performance of our global Duchenne franchise," said Stuart W. Peltz, Ph.D., CEO of PTC... More